Literature DB >> 9492151

The significant increase in incidence of Graves' disease in eastern Serbia during the civil war in the former Yugoslavia (1992 to 1995).

N Paunkovic1, J Paunkovic, O Pavlovic, Z Paunovic.   

Abstract

The incidence of Graves' disease for the last 25 years in eastern Serbia (Yugoslavia), Timok Region is reported. Registration of all Graves' disease patients was conducted in the Endocrinology-Thyroid Unit of Nuclear Medicine Service, Medical Center Zajecar. Timok Region has a population of 315,000 people in seven counties. From 1971 to 1980 an average of 16 new patients per year were registered; from 1981 to 1990 an average of 33 patients per year were registered; in 1995 the number reached 100, and in 1996 there were 148 newly registered patients. Some of the possible factors influencing this significant annual increase of autoimmune hyperthyroidism are discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9492151     DOI: 10.1089/thy.1998.8.37

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  5 in total

Review 1.  The incidence and prevalence of thyroid autoimmunity.

Authors:  Donald S A McLeod; David S Cooper
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

2.  Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves' disease.

Authors:  Roberto Vita; Daniela Lapa; Francesco Trimarchi; Salvatore Benvenga
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

Review 3.  GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis.

Authors:  Matthew J Simmonds
Journal:  Nat Rev Endocrinol       Date:  2013-03-26       Impact factor: 43.330

4.  Stress and hormones.

Authors:  Salam Ranabir; K Reetu
Journal:  Indian J Endocrinol Metab       Date:  2011-01

Review 5.  Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management.

Authors:  Philippe Caron
Journal:  Ann Endocrinol (Paris)       Date:  2020-09-18       Impact factor: 2.478

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.